Researcher from University Hospitals Birmingham Reports on Findings in Crohn's Disease (P548 Ustekinumab shows favourable safety profile and drug persistence rates in patients with Crohn's Disease - results from a tertiary IBD centre)

Media coverage

• Title	Researcher from University Hospitals Birmingham Reports on Findings in Crohn's Disease (P548 Ustekinumab shows favourable safety profile and drug persistence rates in patients with Crohn's Disease - results from a tertiary IBD centre)
  Media name/outlet	Immunotherapy Daily
  Country/Territory	United States
  Date	12/02/24
  Persons	Marietta Iacucci, Subrata Ghosh